.ALX Oncology's stage 2 stomach cancer cells feedback fee has damaged. After seeing its own CD47 blo...
.Yet Another of Ionis Pharmaceuticals' essential midphase readouts has actually disappointed assumpt...
.While Biogen's pharma peers are actually searching for late-stage possessions with little risk, CEO...
.Instil Bio has been a biotech in search of a pipe after it junked its own lead assets over the last...
.Biogen has actually returned liberties to an early Alzheimer's health condition course to Denali Th...
.Welcome to this week's Chutes & Ladders, our summary of significant management hirings, shooting...
.Tip's effort to handle an unusual genetic health condition has actually reached an additional probl...
.Vir Biotechnology's second-quarter revenues file had not been short of major information. The provi...
.Galapagos has paused application in a test of a BCMA-directed CAR-T tissue treatment, pumping the b...
.After much more than 30 years, gene treatment innovator James Wilson M.D., Ph.D., is actually leavi...